These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32296918)

  • 21. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota-based markers predictive of development of Clostridioides difficile infection.
    Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S;
    Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
    Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
    Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
    Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
    Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
    Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
    Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
    Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
    Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.
    Milani C; Ticinesi A; Gerritsen J; Nouvenne A; Lugli GA; Mancabelli L; Turroni F; Duranti S; Mangifesta M; Viappiani A; Ferrario C; Maggio M; Lauretani F; De Vos W; van Sinderen D; Meschi T; Ventura M
    Sci Rep; 2016 May; 6():25945. PubMed ID: 27166072
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota Composition Associated with
    Martinez E; Taminiau B; Rodriguez C; Daube G
    Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890026
    [No Abstract]   [Full Text] [Related]  

  • 31. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by
    Kulecka M; Zeber-Lubecka N; Bałabas A; Czarnowski P; Bagińska K; Głowienka M; Kluska A; Piątkowska M; Dąbrowska M; Waker E; Mikula M; Ostrowski J
    Front Cell Infect Microbiol; 2023; 13():1190910. PubMed ID: 37577378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome and mycobiome in inflammatory bowel disease patients with
    Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
    Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
    Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
    Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients.
    Nycz BT; Dominguez SR; Friedman D; Hilden JM; Ir D; Robertson CE; Frank DN
    PLoS One; 2018; 13(1):e0191232. PubMed ID: 29329346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
    Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
    J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Microbiota of Toxigenic
    Hernández M; de Frutos M; Rodríguez-Lázaro D; López-Urrutia L; Quijada NM; Eiros JM
    Front Microbiol; 2018; 9():3331. PubMed ID: 30697203
    [No Abstract]   [Full Text] [Related]  

  • 40. Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by Clostridioides difficile.
    Herrera G; Castañeda S; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
    Microbiol Res; 2024 Aug; 285():127739. PubMed ID: 38763016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.